Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot study.

CONCLUSIONS: In patients following CAT, extended treatment with NOAC, compared with LMWH, appears to be associated with similar effectiveness and safety. PMID: 31158568 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31158568?dopt=Abstract

Source: Vascular Pharmacology - May 30, 2019 Category: Drugs & Pharmacology Authors: Stepien K, Nowak K, Zalewski J, Pac A, Undas A Tags: Vascul Pharmacol Source Type: research